Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Peter Vanlandschoot

Awards & Distinctions

22 Results

2006

Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection

Philip MeulemanSophia SteyaertLouis LibbrechtSibyl CouventFreya Van HoutteFilip ClinckspoorBernard de HemptinneTania RoskamsPeter VanlandschootGeert Leroux-Roels

A1 Journal Article in CLINICA CHIMICA ACTA

2005

A temperature-dependent inhibitory activity of serum on the capacity of Saccharomyces cerevisiae-derived hepatitis B surface antigen to bind to monocytes

Peter VanlandschootFreya Van HoutteA ROOBROUCKF STELTERF GAVILANESGeert Leroux-Roels

A1 Journal Article in ARCHIVES OF VIROLOGY

Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked

Peter VanlandschootFreya Van HouttePeter UlrichtsJan TavernierGeert Leroux-Roels

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate

Peter VanlandschootFreya Van HoutteBenedikte SerruysGeert Leroux-Roels

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

2003

A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice

Philip MeulemanPeter VanlandschootGeert Leroux-Roels

A1 Journal Article in BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity

Peter VanlandschootFreya Van HoutteF HOEKR NIEUWLANDGeert Leroux-Roels

A1 Journal Article in JOURNAL OF MEDICAL VIROLOGY

Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients

Sophia SteyaertPeter VanlandschootHans Van VlierbergheH DIEPOLDERGeert Leroux-Roels

A1 Journal Article in JOURNAL OF MEDICAL VIROLOGY

The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure

Peter VanlandschootTH CAOLGeert Leroux-Roels

A1 Journal Article in ANTIVIRAL RESEARCH

Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?

Peter VanlandschootGeert Leroux-Roels

A1 Journal Article in TRENDS IN IMMUNOLOGY

2002

Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.

Tinghua CaoIsabelle DesomberePeter VanlandschootM SALLBERGGeert Leroux-Roels

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.

Peter VanlandschootF VAN HOUTTEAnnelies RoobrouckA FARHOUDIGeert Leroux-Roels

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles.

Peter VanlandschootF VAN HOUTTEAnnelies RoobrouckA FARHOUDIF STELTERDL PETERSONJ GOMEZ-GUTIERREZF GAVILANESGeert Leroux-Roels

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes.

Peter VanlandschootAnnelies RoobrouckF VAN HOUTTEGeert Leroux-Roels

A1 Journal Article in BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

2001

Hepatitis B virus core antigen binds and activates naive human B cells in vivo: Studies with a human PBL-NOD/SCID mouse model.

Tinghua CaoU LAZDINAIsabelle DesomberePeter VanlandschootDR MILICHM SALLBERGGeert Leroux-Roels

A1 Journal Article in JOURNAL OF VIROLOGY

Prevention of hepatitis B infections: Vaccination and its limitations

Geert Leroux-RoelsT CAOA DE KNIBBERPhilip MeulemanA ROOBROUCKA FARHOUDIPeter VanlandschootIsabelle Desombere

A1 Journal Article in ACTA CLINICA BELGICA

1998

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.

Peter VanlandschootE BEIRNAERTB BARREREL CALDERB MILLARS WHARTONWilly Min JouWalther Fiers

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A.

Wim MartinetTom DerooXavier SaelensEls BeirnaertPeter VanlandschootRoland ContrerasWalther FiersWilly Min Jou

A1 Journal Article in ARCHIVES OF VIROLOGY

pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin.

Peter VanlandschootEls BeirnaertJohan GrootenWilly Min JouWalther Fiers

A1 Journal Article in ARCHIVES OF VIROLOGY

1996

Karakterisering van recombinant hemagglutinine en isolatie van kruisreagerende monoclonale antilichamen

Peter VanlandschootWalther Fiers

Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells.

Peter VanlandschootEls BeirnaertSabine NeirynckXavier SaelensWilly Min JouWalther Fiers

A1 Journal Article in ARCHIVES OF VIROLOGY

1995

A FAIRLY CONSERVED EPITOPE ON THE HEMAGGLUTININ OF INFLUENZA-A (H3N2) VIRUS WITH VARIABLE ACCESSIBILITY TO NEUTRALIZING ANTIBODY.

Peter VanlandschootEls BeirnaertS DEWILDEXavier SaelensT BESTEBROERJ DEJONGWilly Min JouWalther Fiers

A1 Journal Article in VIROLOGY

1993

Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus

Peter VanlandschootGeert MaertensWilly Min JouWalther Fiers

A1 Journal Article in VACCINE